by Lori Solomon The U.S. Food and Drug Administration has approved UCB’ Zilbrysq (zilucoplan) for the treatment of adults with generalized myasthenia gravis. Zilbrysq is a targeted peptide inhibitor of complement component 5 (C5) and is approved as a once-daily, self-administered, targeted therapy in patients with anti-acetylcholine receptor (AChR)-antibody-positive generalized myasthenia gravis. The approval of...
Undiagnosed: More than 7 million Americans unaware they have mild cognitive impairment
by Katharine Gammon, University of Southern California Credit: Pixabay/CC0 Public DomainFor many people, forgetting your keys or struggling to plan tasks can seem like a normal part of the aging process. But those lapses can actually be symptoms of something more serious: mild cognitive impairment, or MCI, which could be an early sign of Alzheimer’s disease....
T-cell receptor discovery has huge potential for engineering custom immune responses
by Institute for Systems Biology Credit: Pixabay/CC0 Public DomainT cells are soldiers on the front lines of the human immune system. They are responsible for many important roles, including attacking viral- or bacterial-infected cells and certain cancer cells, and immunological memory—remembering the specific pathogens or the cancer signatures that originally trigger T cells. Until now,...
Simple blood test can help diagnose bipolar disorder
by University of Cambridge Credit: Pixabay/CC0 Public DomainResearchers have developed a new way of improving diagnosis of bipolar disorder that uses a simple blood test to identify biomarkers associated with the condition. The researchers, from the University of Cambridge, used a combination of an online psychiatric assessment and a blood test to diagnose patients with bipolar...
10 myths about multivitamins you will regret believing till now
TIMESOFINDIA.COM | Last updated on -Oct 24, 2023, 07:00 IST 01/11 – We self-prescribe multivitamin pills, without weighing their pros and cons Multivitamin pills are among the most popular dietary supplements worldwide. Marketed as a convenient way to fill nutritional gaps, multivitamins have earned both praise and criticism. Unfortunately, myths and misconceptions often surround these supplements,...
Two recent studies quantify distortions to the risk-benefit ratio.
Updated October 24, 2023 KEY POINTSNew research finds widely prescribed drugs are much less effective than their published record suggests.One study saw financial conflicts of interest driving whether unfavorable results were reported and where.A new study of FDA data finds the recorded efficacy of alprazolam XR inflated by more than 40 percent. Source: Iren Moroz /...
Kids with Omicron non-infectious after three days, vaccination status irrelevant
Dr. Sushama R. Chaphalkar, PhD.By Dr. Sushama R. Chaphalkar, PhD.Oct 24 2023Reviewed by Susha Cheriyedath, M.Sc. In a cohort study published in the Journal of American Medical Association (JAMA) Pediatrics, researchers from California examined the children who tested positive for coronavirus disease 2019 (COVID-19). They evaluated the duration of infectivity (culturable virus shedding) of the...
Analysis suggests climate change, population growth could supercharge malaria risk
News brief October 24, 2023Lisa Schnirring for University of MinnesotaAn analysis published by the Washington Post yesterday, based on modeling projections and the situation unfolding in Mozambique, suggests that climate change and demographic growth could put 5 billion more people at risk for malaria by 2040. malaria bednetDFID /Flickr ccThe analysis said longer transmission seasons...
Flu shots may protect against the risk of Alzheimer’s, related dementias
Some studies have shown that vaccinated individuals appear less likely than the unvaccinated to develop dementia, although scientists aren’t sure why By Marlene Cimons – Washington PostOctober 25, 2023 at 7:00 a.m. EDT There are many good reasons to get a flu shot this fall, but here’s one that might surprise you: It could protect...
Ketamine’s Depression Benefits Could Be Due to Hope
(Adobe Stock)Tuesday, 24 October 2023 04:38 PM EDT The party drug ketamine has gotten a lot of notice for its potential to help people with severe and persistent depression who haven’t responded to other treatments. But a new study has discovered the drug’s effect may be in the heads of patients who take it. Researchers...